Cargando…
Systems Chronotherapeutics
Chronotherapeutics aim at treating illnesses according to the endogenous biologic rhythms, which moderate xenobiotic metabolism and cellular drug response. The molecular clocks present in individual cells involve approximately fifteen clock genes interconnected in regulatory feedback loops. They are...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394920/ https://www.ncbi.nlm.nih.gov/pubmed/28351863 http://dx.doi.org/10.1124/pr.116.013441 |
_version_ | 1783229794794602496 |
---|---|
author | Ballesta, Annabelle Innominato, Pasquale F. Dallmann, Robert Rand, David A. Lévi, Francis A. |
author_facet | Ballesta, Annabelle Innominato, Pasquale F. Dallmann, Robert Rand, David A. Lévi, Francis A. |
author_sort | Ballesta, Annabelle |
collection | PubMed |
description | Chronotherapeutics aim at treating illnesses according to the endogenous biologic rhythms, which moderate xenobiotic metabolism and cellular drug response. The molecular clocks present in individual cells involve approximately fifteen clock genes interconnected in regulatory feedback loops. They are coordinated by the suprachiasmatic nuclei, a hypothalamic pacemaker, which also adjusts the circadian rhythms to environmental cycles. As a result, many mechanisms of diseases and drug effects are controlled by the circadian timing system. Thus, the tolerability of nearly 500 medications varies by up to fivefold according to circadian scheduling, both in experimental models and/or patients. Moreover, treatment itself disrupted, maintained, or improved the circadian timing system as a function of drug timing. Improved patient outcomes on circadian-based treatments (chronotherapy) have been demonstrated in randomized clinical trials, especially for cancer and inflammatory diseases. However, recent technological advances have highlighted large interpatient differences in circadian functions resulting in significant variability in chronotherapy response. Such findings advocate for the advancement of personalized chronotherapeutics through interdisciplinary systems approaches. Thus, the combination of mathematical, statistical, technological, experimental, and clinical expertise is now shaping the development of dedicated devices and diagnostic and delivery algorithms enabling treatment individualization. In particular, multiscale systems chronopharmacology approaches currently combine mathematical modeling based on cellular and whole-body physiology to preclinical and clinical investigations toward the design of patient-tailored chronotherapies. We review recent systems research works aiming to the individualization of disease treatment, with emphasis on both cancer management and circadian timing system–resetting strategies for improving chronic disease control and patient outcomes. |
format | Online Article Text |
id | pubmed-5394920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The American Society for Pharmacology and Experimental Therapeutics |
record_format | MEDLINE/PubMed |
spelling | pubmed-53949202017-05-02 Systems Chronotherapeutics Ballesta, Annabelle Innominato, Pasquale F. Dallmann, Robert Rand, David A. Lévi, Francis A. Pharmacol Rev Review Articles Chronotherapeutics aim at treating illnesses according to the endogenous biologic rhythms, which moderate xenobiotic metabolism and cellular drug response. The molecular clocks present in individual cells involve approximately fifteen clock genes interconnected in regulatory feedback loops. They are coordinated by the suprachiasmatic nuclei, a hypothalamic pacemaker, which also adjusts the circadian rhythms to environmental cycles. As a result, many mechanisms of diseases and drug effects are controlled by the circadian timing system. Thus, the tolerability of nearly 500 medications varies by up to fivefold according to circadian scheduling, both in experimental models and/or patients. Moreover, treatment itself disrupted, maintained, or improved the circadian timing system as a function of drug timing. Improved patient outcomes on circadian-based treatments (chronotherapy) have been demonstrated in randomized clinical trials, especially for cancer and inflammatory diseases. However, recent technological advances have highlighted large interpatient differences in circadian functions resulting in significant variability in chronotherapy response. Such findings advocate for the advancement of personalized chronotherapeutics through interdisciplinary systems approaches. Thus, the combination of mathematical, statistical, technological, experimental, and clinical expertise is now shaping the development of dedicated devices and diagnostic and delivery algorithms enabling treatment individualization. In particular, multiscale systems chronopharmacology approaches currently combine mathematical modeling based on cellular and whole-body physiology to preclinical and clinical investigations toward the design of patient-tailored chronotherapies. We review recent systems research works aiming to the individualization of disease treatment, with emphasis on both cancer management and circadian timing system–resetting strategies for improving chronic disease control and patient outcomes. The American Society for Pharmacology and Experimental Therapeutics 2017-04 2017-04 /pmc/articles/PMC5394920/ /pubmed/28351863 http://dx.doi.org/10.1124/pr.116.013441 Text en Copyright © 2017 by The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the CC BY Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Articles Ballesta, Annabelle Innominato, Pasquale F. Dallmann, Robert Rand, David A. Lévi, Francis A. Systems Chronotherapeutics |
title | Systems Chronotherapeutics |
title_full | Systems Chronotherapeutics |
title_fullStr | Systems Chronotherapeutics |
title_full_unstemmed | Systems Chronotherapeutics |
title_short | Systems Chronotherapeutics |
title_sort | systems chronotherapeutics |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394920/ https://www.ncbi.nlm.nih.gov/pubmed/28351863 http://dx.doi.org/10.1124/pr.116.013441 |
work_keys_str_mv | AT ballestaannabelle systemschronotherapeutics AT innominatopasqualef systemschronotherapeutics AT dallmannrobert systemschronotherapeutics AT randdavida systemschronotherapeutics AT levifrancisa systemschronotherapeutics |